Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...
Abbott, the creator of continuous glucose monitors, launched the new Assist feature at CES 2026. Part of the Libre app, it ...
The GENESIS II Total Knee System has grown to become one of the most trusted total knee systems on the market. Cutting edge instrumentation, such as the user friendly MIS system and the ream-thru ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback